Palivizumab: References

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. PEDIATRICS. 2014;134(2):e620-e638. doi:10.1542/peds.2014-1666. http://pediatrics.aappublications.org/content/pediatrics/134/2/415.full.pdf. Accessed April 2, 2017.

Andabaka T, Nickerson JW, Rojas-Reyes, M, et al. Palivizumab for reducing the risk of severe RSV infection in children. Cochrane. http://summaries.cochrane.org/CD006602/palivizumab-for-reducing-the-risk-of-severe-rsv-infection-in-children. April 30, 2013. Accessed April 2, 2017.

Barr FE, Graham BS. Respiratory syncytial virus infection: Prevention. UpToDate. https://www.uptodate.com/contents/respiratory-syncytial-virus-infection-prevention?source=related_link. Updated 11/7/2016. Accessed 4/2/2017.